Palisade Bio (PALI) Cash from Investing Activities (2010 - 2022)
Palisade Bio (PALI) reported Cash from Investing Activities of -$10000.0 for Q4 2022, up 97.13% quarter-over-quarter from -$348000.0 in Q3 2021.
Palisade Bio (PALI) Cash from Investing Activities (2010 - 2022) Analysis & Trends
Palisade Bio (PALI) has 12 years of Cash from Investing Activities data on file, last reported at -$10000.0 in Q4 2022.
- Cash from Investing Activities for Q4 2022 came in at -$10000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was -$10000.0 (changed 0.0% YoY), and the FY2023 annual result was -$4000.0, up 60.0% from the prior year.
- Cash from Investing Activities climbed to -$10000.0 in Q4 2022 per PALI's latest filing, from -$348000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $5.0 million in Q1 2018 and troughed at -$348000.0 in Q3 2021.
- A 4-year average of $773381.0 and a median of -$1357.0 in 2018 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2018 and 2021: Cash from Investing Activities tumbled 320.1% in 2018, then slumped 34900.0% in 2021.
- A 4-year view of Cash from Investing Activities shows it stood at -$1714.0 in 2018, then surged by 41.66% to -$1000.0 in 2020, then slumped by 34700.0% to -$348000.0 in 2021, then jumped by 97.13% to -$10000.0 in 2022.
- Business Quant data shows PALI's Cash from Investing Activities at -$10000.0 in Q4 2022, -$348000.0 in Q3 2021, and -$1000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -10,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2021 | -348,000.00 |
| Sep 30, 2021 | -348,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Dec 31, 2018 | -1,714.00 |
| Dec 31, 2018 | -1,714.00 |
| Mar 31, 2018 | 5.00 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | -408.00 |
| Dec 31, 2017 | -408.00 |
| Sep 30, 2017 | -190.00 |
| Sep 30, 2017 | -190.00 |
| Dec 31, 2016 | -5.03 Mn |
| Dec 31, 2016 | -5.03 Mn |
| Jun 30, 2016 | -100,926.00 |
| Jun 30, 2016 | -100,926.00 |